{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:22:58Z","timestamp":1785813778181,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Government of Malaysia Ministry of Higher Education","doi-asserted-by":"publisher","award":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"],"award-info":[{"award-number":["FRGS\/1\/2019\/STG01\/UKM\/02\/3"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116828","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:51:14Z","timestamp":1725627074000},"page":"116828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Design and synthesis of pyrano[2,3-c]pyrazole-4-aminoquinoline hybrids as effective antimalarial compounds"],"prefix":"10.1016","volume":"279","author":[{"given":"Ravindar","family":"Lekkala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Hong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevin Rizal","family":"Feroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Aqilah Zahirah Binti","family":"Norazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amatul Hamizah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Aishah","family":"Hasbullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norzila","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani Kartini","family":"Agustar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee Ling","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-4290","authenticated-orcid":false,"given":"Nurul Izzaty","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116828_bib1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1172\/JCI33996","article-title":"Malaria: progress, perils, and prospects for eradication","volume":"118","author":"Greenwood","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2024.116828_bib2","unstructured":"WHO Malaria Report 2022, http:\/\/www.who.int\/teams\/globalmalariaprogramme\/reports\/world-malaria-report-2022 (accessed in February 2023)."},{"key":"10.1016\/j.ejmech.2024.116828_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of antimalarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116828_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115458","article-title":"Recent developments in antimalarial activities of 4-aminoquinoline derivatives","volume":"256","author":"Ravindar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115694","article-title":"Triazole hybrid compounds: a new frontier in malaria treatment","volume":"259","author":"Ravindar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib6","article-title":"Pyrazole and pyrazoline derivatives as antimalarial agents: a key review","volume":"183","author":"Ravindar","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2024.116828_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review","volume":"193","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib9","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/molecules24193601","article-title":"Combination therapy strategies for the treatment of malaria","volume":"24","author":"Alven","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116828_bib10","article-title":"Hybrid molecules with a dual mode of action: dream or reality?","volume":"69","author":"Meunier","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2024.116828_bib11","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib12","doi-asserted-by":"crossref","DOI":"10.1039\/C5RA16361G","article-title":"4-Aminoquinoline-hybridization en route towards the development of rationally designed antimalarial agents","volume":"5","author":"Raj","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116828_bib13","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/molecules26092601","article-title":"Hybrid drugs-A strategy for overcoming anticancer drug resistance?","volume":"26","author":"Szumilak","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116828_bib14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/ph15091071","article-title":"Concept of hybrid drugs and recent advancements in anticancer hybrids","volume":"15","author":"Singh","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116828_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jama.1946.02870160015006","article-title":"Activity of a new antimalarial agent, chloroquine (SN 7618): statement approved by the board for coordination of malarial studies","volume":"130","author":"Loeb","year":"1946","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejmech.2024.116828_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2013.07.004","article-title":"Chloroquine: modes of action of an undervalued drug","volume":"153","author":"Thom\u00e9","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejmech.2024.116828_bib17","first-page":"3463","article-title":"4-Aminoquinoline hybridization concept as alternative antiplasmodial agent","volume":"51","author":"Zubir","year":"2022","journal-title":"Sains Malays."},{"key":"10.1016\/j.ejmech.2024.116828_bib18","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.tetlet.2019.05.054","article-title":"Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity","volume":"60","author":"Huang","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2024.116828_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.11.021","article-title":"N-Substituted aminoquinoline-pyrimidine hybrids: synthesis, in vitro antimalarial activity evaluation and docking studies","volume":"162","author":"Maurya","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejmech.2017.11.033","article-title":"Microwave-promoted facile access to 4-aminoquinolinephthalimides: synthesis and anti-plasmodial evaluation","volume":"143","author":"Rani","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.04.006","article-title":"Substituted 1,3-dioxoisoindoline-4-aminoquinolines coupled via amide linkers: synthesis, antiplasmodial and cytotoxic evaluation","volume":"88","author":"Rani","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4155\/fmc-2019-0260","article-title":"Design, synthesis, heme binding and density functional theory studies of isoindoline-dione-4-aminoquinolines as potential antiplasmodials","volume":"12","author":"Rani","year":"2020","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib23","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.bmc.2019.01.044","article-title":"New hybrid trifluoromethylquinolines as antiplasmodium agents","volume":"27","author":"da Silva","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib24","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.3390\/molecules26134093","article-title":"Synthesis and evaluation of chalcone-quinoline based molecular hybrids as potential anti-malarial agents","volume":"26","author":"Vinindwa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116828_bib25","article-title":"Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents","volume":"198","author":"de Walle","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib26","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acsmedchemlett.2c00078","article-title":"Synthesis, anti-plasmodial activities, and mechanistic insights of 4-aminoquinoline-triazolopyrimidine hybrids","volume":"13","author":"Chowdhary","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116828_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114408","article-title":"Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents","volume":"238","author":"Poje","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103094","article-title":"Design, synthesis and biological evaluation of 4-Aminoquinoline-guanylthiourea derivatives as antimalarial agents","volume":"91","author":"Bhagat","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejmech.2018.08.063","article-title":"Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies","volume":"158","author":"Bonilla-Ram\u00edrez","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bioorg.2018.06.012","article-title":"Design, Synthesis and Antiplasmodial activity of novel imidazole derivatives based on 7-chloro-4-aminoquinoline","volume":"80","author":"Kondaparla","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib31","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.bmc.2019.03.061","article-title":"Synthesis and structure-activity relationships for new 6-fluoroquinoline derivatives with antiplasmodial activity","volume":"27","author":"Hochegger","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib32","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2174\/1570193X19666211220141622","article-title":"One-pot synthesis of pyrano[2,3-c]pyrazole derivatives via multicomponent reactions (MCRs) and their applications in medicinal chemistry","volume":"19","author":"Biswas","year":"2022","journal-title":"Mini-Reviews Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib33","first-page":"52","article-title":"Synthesis and molecular docking studies of pyrano[2,3-c] pyrazole-3-carboxylates as potential inhibitors of Plasmodium falciparum","volume":"22","author":"Shamsuddin","year":"2020","journal-title":"Malays. J. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib34","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1021\/jm501987h","article-title":"Inhibitors of plasmodial serine hydroxymethyltransferase (SHMT): cocrystal structures of pyrazolopyrans with potent blood- and liver-stage activities","volume":"58","author":"Witschel","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib35","first-page":"3463","article-title":"4-Aminoquinoline hybridization concept as alternative antiplasmodial agent","volume":"51","author":"Zubir","year":"2022","journal-title":"Sains Malays."},{"key":"10.1016\/j.ejmech.2024.116828_bib36","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/ph14111174","article-title":"Synthesis, molecular docking, and antimalarial activity of hybrid 4-Aminoquinoline-pyrano[2,3-c]pyrazole derivatives","volume":"14","author":"Shamsuddin","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2024.116828_bib37","first-page":"149","article-title":"Practical synthesis and electronic study of non-spiro and spiropyrano[2,3-c]pyrazole-3-carboxyate derivatives via uncatalyzed domino one-pot, four-component reactions, Org","volume":"11","author":"Mohammat","year":"2018","journal-title":"Commun. Now."},{"key":"10.1016\/j.ejmech.2024.116828_bib38","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/jm200149e","article-title":"Enone- and chalcone-chloroquinoline hybrid analogues: in silico guided design, synthesis, antiplasmodial activity, in vitro metabolism, and mechanistic studies","volume":"54","author":"Guantai","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib39","series-title":"Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof","author":"Cazelles","year":"2011"},{"key":"10.1016\/j.ejmech.2024.116828_bib40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1570180813666160622092839","article-title":"Analysis of the applicability and use of Lipinski's rule for central nervous system drugs","volume":"13","author":"Fernandes","year":"2016","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2024.116828_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2024.116828_bib42","doi-asserted-by":"crossref","DOI":"10.1063\/1.4937259","article-title":"ADME-Tox profiles of some food additives and pesticides","volume":"1694","author":"Craciun","year":"2015","journal-title":"AIP Conf. Proc."},{"key":"10.1016\/j.ejmech.2024.116828_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imu.2016.09.004","article-title":"Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets","volume":"5","author":"Gurung","year":"2016","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.ejmech.2024.116828_bib44","first-page":"1839","article-title":"Fsp3: a new parameter for drug-likeness","volume":"25","author":"Wei","year":"2020","journal-title":"Drug Discov"},{"key":"10.1016\/j.ejmech.2024.116828_bib45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/3.3.239","article-title":"Penetration of the blood brain barrier by metronidazole and tinidazole","volume":"3","author":"Jokipii","year":"1977","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2024.116828_bib46","series-title":"Medical Genetics Summaries","article-title":"Omeprazole therapy and CYP2C19 genotype","author":"Dean","year":"2012"},{"key":"10.1016\/j.ejmech.2024.116828_bib47","first-page":"128","volume":"1","author":"Sonia","year":"2014"},{"key":"10.1016\/j.ejmech.2024.116828_bib48","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2024.116828_bib49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2174\/1570180819666220922103109","article-title":"Molecular docking: principles, advances, and its applications in drug discovery","volume":"21","author":"Muhammed","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2024.116828_bib50","doi-asserted-by":"crossref","DOI":"10.1039\/D3RA05361J","article-title":"Chalcone Mannich base derivatives: synthesis, antimalarial activities against Plasmodium knowlesi, and molecular docking analysis","volume":"13","author":"Syahri","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116828_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27462","article-title":"Preliminary insight on diarylpentanoids as potential antimalarials: in silico, in vitro pLDH and in vivo zebrafish toxicity assessment","volume":"10","author":"Ramli","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejmech.2024.116828_bib52","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phymed.2008.02.001","article-title":"In vitro antiplasmodial activity of extract and constituents from Esenbeckia febrifuga, a plant traditionally used to treat malaria in the Brazilian Amazon","volume":"15","author":"Dolabela","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116828_bib53","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116828_bib54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2875-10-85","article-title":"Icacina senegalensis (Icacinaceae), traditionally used for the treatment of malaria, inhibits in vitro Plasmodium falciparum growth without host cell toxicity","volume":"10","author":"Sarr","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116828_bib55","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2024.116828_bib56","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.274.15.10213","article-title":"Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase","volume":"274","author":"Read","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib57","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ejmech.2024.116828_bib58","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116828_bib59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.116828_bib60","first-page":"361","article-title":"Cultivation of erythrocytic stages","volume":"55","author":"Trager","year":"1997","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ejmech.2024.116828_bib61","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium Falciparum erythrocytic stages in cultur","volume":"65","author":"Lambros","year":"1979","journal-title":"J. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116828_bib62","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/1475-2875-12-425","article-title":"Susceptibility of human Plasmodium knowlesi infections to anti-malarials","volume":"12","author":"Fatih","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2024.116828_bib63","doi-asserted-by":"crossref","first-page":"34e39","DOI":"10.1016\/j.exppara.2006.02.006","article-title":"Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates","volume":"114","author":"Kosaisavee","year":"2006","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2024.116828_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01334-07","article-title":"Determinants of in vitro drug susceptibility testing of Plasmodium vivax","volume":"52","author":"Russell","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116828_bib65","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.1016\/j.bmc.2009.08.003","article-title":"Synthesis and antimalarial activity of new chloroquine analogues carrying a multifunctional linear side chain","volume":"17","author":"Iwaniuk","year":"2009","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424007098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T20:39:14Z","timestamp":1731271154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424007098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S0223523424007098"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116828","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of pyrano[2,3-c]pyrazole-4-aminoquinoline hybrids as effective antimalarial compounds","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116828"}}